Aldehyde dehydrogenase 1 (ALDH1) expression is an independent prognostic factor in triple negative breast cancer (TNBC)
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
General Medicine
Reference21 articles.
1. Triple-negative breast cancer: disease entity or title of convenience;Carey;Nat Rev Clin Oncol,2010
2. Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma;Nielsen;Clin Cancer Res,2004
3. Stem cell marker aldehyde dehydrogenase 1 (ALDH1)-expressing cells are enriched in triple-negative breast cancer;Huihui;Int J Biol Markers,2013
4. Enriched CD44+/CD24− population drives the aggressive phenotypes presented in triple-negative breast cancer (TNBC);Fei;Cancer Lett,2014
5. Cancer stem cells in solid tumors: accumulating evidence and unresolved questions;Visvader;Nat Rev Cancer,2008
Cited by 51 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Ferroptosis as a promising targeted therapy for triple negative breast cancer;Breast Cancer Research and Treatment;2024-06-14
2. Chemoresistance to additive PARP/PI3K dual inhibition in triple-negative breast cancer cell lines is associated with adaptive stem cell-like prevalence;2024-04-30
3. Are embryonic stem cell markers and ALDH1A1 relevant in the context of breast cancer estrogen positivity?;Cancer Medicine;2024-02
4. The prognostic value of stem cell markers in triple-negative breast cancer;Pathology and Oncology Research;2023-12-22
5. Breast Cancer Chemoresistance: Insights into the Regulatory Role of lncRNA;International Journal of Molecular Sciences;2023-11-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3